FDA suggests safety warning for Eli Lilly Alzheimer’s drug
https://seekingalpha.com/news/4113676-eli-lilly-alzheimers-drug-should-come-safety-warning?source=feed_sector_healthcare
Jun 06, 2024 - The US FDA has suggested a safety warning for Eli Lilly's (LLY) Alzheimer's therapy, donanemab, ahead of a meeting on its marketing application. Read more here.
0
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
https://www.cnbc.com/2024/06/05/alphabet-taps-eli-lillys-anat-ashkenazi-as-new-cfo.html
Jun 05, 2024 - Ashkenazi will replace Ruth Porat, who will become president and chief investment officer of the company after nearly a decade as CFO.
0
Biogen favored at RBC as Eli Lilly awaits FDA AdCom on Alzheimer’s drug
https://seekingalpha.com/news/4113279-biogen-stock-favored-rbc-lilly-awaits-alzheimers-drug?source=feed_sector_healthcare
Jun 05, 2024 - RBC Capital Markets maintains a bullish view on Biogen (BIIB) despite Eli Lilly's (LLY) upcoming FDA decision on its Alzheimer's therapy donanemab. Read more here.
0
Eli Lilly wins favorable terms for obesity drug use in U.K.
https://seekingalpha.com/news/4112822-eli-lilly-obesity-drug-recommended-use-uk?source=feed_sector_healthcare
Jun 04, 2024 - The UK health authorities recommend Eli Lilly's (LLY) tirzepatide for obesity, under better terms than Novo Nordisk's (NVO) rival drug semaglutide. Read more here.
0
This Is the Biggest Risk for Eli Lilly and Novo Nordisk Investors
https://www.fool.com/investing/2024/06/01/this-biggest-risk-for-eli-lilly-and-novo-nordisk/?source=iedfolrf0000001
Jun 01, 2024 - These stocks are trading at sky-high valuations which could make them vulnerable to sell-offs.
0
Top Research Reports for Eli Lilly, T-Mobile & BHP
https://www.zacks.com/commentary/2282096/top-research-reports-for-eli-lilly-t-mobile-bhp?cid=CS-ZC-FT-research_daily-2282096
May 31, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), T-Mobile US, Inc. (TMUS) and BHP Group Limited (BHP).
0
Eli Lilly (LLY) to Ramp Up Indiana Site for Mounjaro, Zepbound
https://www.zacks.com/stock/news/2279236/eli-lilly-lly-to-ramp-up-indiana-site-for-mounjaro-zepbound?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2279236
May 27, 2024 - Since 2020, Eli Lilly (LLY) has committed more than $18 billion to building new manufacturing sites as well as updating existing manufacturing facilities.
0
Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earnings
https://www.cnbc.com/2024/05/24/eli-lilly-big-glp-1-investment-plus-crm-bby-fl-cost-earnings-next-week.html
May 24, 2024 - The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.
0
SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?
https://seekingalpha.com/news/4108152-sa-roundtable-are-eli-lilly-and-novo-nordisk-overvalued?source=feed_sector_healthcare
May 19, 2024 - Are Mounjaro maker Eli Lilly (LLY) and Ozempic marketer Novo Nordisk (NVO) overvalued? Seeking Alpha analysts weigh in on the weight-loss drug stocks. Read more here.
0
Top Research Reports for Microsoft, Eli Lilly & Costco
https://www.zacks.com/commentary/2275480/top-research-reports-for-microsoft-eli-lilly-costco?cid=CS-ZC-FT-research_daily-2275480
May 17, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).
0